» Articles » PMID: 15039768

Methadone Maintenance Reduces Heroin- and Cocaine-induced Relapse Without Affecting Stress-induced Relapse in a Rodent Model of Poly-drug Use

Overview
Date 2004 Mar 25
PMID 15039768
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Although it is well established that methadone can be an effective treatment for opiate addiction, it is not clear how methadone maintenance affects cocaine use and cravings in individuals who self-administer both opiates and cocaine. In our attempt to explore the effect of methadone maintenance on the effects of cocaine, we first assessed the locomotor stimulatory effects of cocaine in rats maintained on methadone (0, 10, 20, or 30 mg/kg/day, via osmotic minipumps). Chronic methadone elevated baseline locomotion in a dose-dependent manner and did not reduce the direct stimulatory effects of cocaine (5 mg/kg). We then investigated the effects of the highest methadone maintenance dose (30 mg/kg/day) on heroin and cocaine seeking in extinction, and when it was precipitated by exposure to heroin, cocaine, or foot-shock stress in rats trained to self-administer both drugs in the same experimental context (heroin 0.05 mg/kg/inf; cocaine 0.5 mg/kg/inf, eight 3-h sessions each). In tests of reinstatement, rats responded selectively on the appropriate drug-associated lever after priming injections of heroin (0.25 mg/kg) or cocaine (20 mg/kg). Methadone maintenance blocked both cocaine- and heroin-induced reinstatement, but not stress-induced reinstatement, which was not lever selective. These results suggest that although methadone maintenance may not reduce the direct stimulatory effects of cocaine, it has the potential to reduce both spontaneous and cocaine-primed cocaine-seeking behavior.

Citing Articles

A rat model of operant negative reinforcement in opioid-dependent males and females.

Chow J, Pitts K, Chabot J, Ito R, Shaham Y Psychopharmacology (Berl). 2024; 241(9):1791-1813.

PMID: 38642101 DOI: 10.1007/s00213-024-06594-w.


Therapeutics for Substance-Using Women: The Need to Elucidate Sex-Specific Targets for Better-Tailored Treatments.

Fox H, Milivojevic V, Sinha R Handb Exp Pharmacol. 2023; 282:127-161.

PMID: 37592081 DOI: 10.1007/164_2023_687.


Efficacy of a Brief Mindfulness Intervention in Underserved Individuals Receiving Inpatient Treatment for Opioid Use Disorder: A Pilot Study.

Kennelly N, Ray S Cureus. 2023; 15(6):e40525.

PMID: 37461794 PMC: 10350319. DOI: 10.7759/cureus.40525.


Opioid withdrawal: role in addiction and neural mechanisms.

Monroe S, Radke A Psychopharmacology (Berl). 2023; 240(7):1417-1433.

PMID: 37162529 PMC: 11166123. DOI: 10.1007/s00213-023-06370-2.


The Evolving Role of Animal Models in the Discovery and Development of Novel Treatments for Psychiatric Disorders.

Teal L, Ingram S, Bubser M, McClure E, Jones C Adv Neurobiol. 2023; 30:37-99.

PMID: 36928846 DOI: 10.1007/978-3-031-21054-9_3.